CDNS vs. CPRX
CDNS (Cadence Design Systems, Inc.) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. CDNS operates in Software - Application (Technology), while CPRX operates in Biotechnology (Healthcare). Over the past 10 years, CDNS returned 31.77%/yr vs 46.26%/yr for CPRX. At a 0.18 correlation, their price movements are largely independent.
Performance
CDNS vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDNS achieves a 23.16% return, which is significantly lower than CPRX's 34.36% return. Over the past 10 years, CDNS has underperformed CPRX with an annualized return of 31.77%, while CPRX has yielded a comparatively higher 46.26% annualized return.
CDNS
- 1D
- 0.32%
- 1M
- 8.58%
- YTD
- 23.16%
- 6M
- 19.10%
- 1Y
- 25.05%
- 3Y*
- 17.22%
- 5Y*
- 24.39%
- 10Y*
- 31.77%
CPRX
- 1D
- -0.03%
- 1M
- 0.64%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 29.11%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
CDNS vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CDNS Cadence Design Systems, Inc. | 23.16% | 4.03% | 10.31% | 69.55% | -13.80% | 36.59% | 96.70% | 59.52% | 3.97% | 65.82% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between CDNS and CPRX is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.20 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006 | 0.18 |
Fundamentals
CDNS:
$105.37B
CPRX:
$3.98B
CDNS:
$4.28
CPRX:
$1.74
CDNS:
89.86
CPRX:
18.02
CDNS:
6.85
CPRX:
0.32
CDNS:
19.03
CPRX:
6.68
CDNS:
12.08
CPRX:
3.93
CDNS:
$5.53B
CPRX:
$596.96M
CDNS:
$4.91B
CPRX:
$378.23M
CDNS:
$1.87B
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDNS vs. CPRX — Risk / Return Rank
CDNS
CPRX
CDNS vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cadence Design Systems, Inc. (CDNS) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDNS | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.24 | ||
| Sortino ratioReturn per unit of downside risk | -0.22 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 1.18 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.87 | 1.52 | -0.65 |
| Martin ratioReturn relative to average drawdown | 1.84 | 3.46 | -1.61 |
Loading charts...
Drawdowns
CDNS vs. CPRX - Drawdown Comparison
The maximum CDNS drawdown since its inception was -93.13%, roughly equal to the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CDNS and CPRX.
Loading charts...
Drawdown Indicators
| CDNS | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.13% | -94.25% | +1.12% |
Max Drawdown (1Y)Largest decline over 1 year | -28.85% | -19.18% | -9.67% |
Max Drawdown (3Y)Largest decline over 3 years | -29.05% | -27.29% | -1.76% |
Max Drawdown (5Y)Largest decline over 5 years | -29.59% | -45.37% | +15.78% |
Max Drawdown (10Y)Largest decline over 10 years | -32.12% | -64.87% | +32.75% |
Current DrawdownCurrent decline from peak | -7.55% | -0.03% | -7.52% |
Average DrawdownAverage peak-to-trough decline | -39.62% | -51.96% | +12.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.63% | 9.84% | +3.79% |
Volatility
CDNS vs. CPRX - Volatility Comparison
Cadence Design Systems, Inc. (CDNS) has a higher volatility of 16.52% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.47%. This indicates that CDNS's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDNS | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.52% | 0.47% | +16.05% |
Volatility (6M)Calculated over the trailing 6-month period | 31.73% | 23.17% | +8.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.94% | 33.28% | +5.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 36.17% | 47.77% | -11.60% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.12% | 60.39% | -26.27% |
Dividends
CDNS vs. CPRX - Dividend Comparison
Neither CDNS nor CPRX has paid dividends to shareholders.
Financials
CDNS vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Cadence Design Systems, Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CDNS vs. CPRX - Profitability Comparison
CDNS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cadence Design Systems, Inc. reported a gross profit of 1.41B and revenue of 1.47B. Therefore, the gross margin over that period was 95.9%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
CDNS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cadence Design Systems, Inc. reported an operating income of 431.33M and revenue of 1.47B, resulting in an operating margin of 29.3%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
CDNS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cadence Design Systems, Inc. reported a net income of 335.66M and revenue of 1.47B, resulting in a net margin of 22.8%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
CDNS and CPRX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDNS has higher volatility (16.52%) compared to CPRX (0.47%). In terms of maximum drawdown, CDNS dropped -93.13% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (0.89 vs 0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDNS and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer